首页> 外文OA文献 >Directed selection of recombinant human monoclonal antibodies to herpes simplex virus glycoproteins from phage display libraries.
【2h】

Directed selection of recombinant human monoclonal antibodies to herpes simplex virus glycoproteins from phage display libraries.

机译:从噬菌体展示文库中直接选择针对单纯疱疹病毒糖蛋白的重组人单克隆抗体。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Human monoclonal antibodies have considerable potential in the prophylaxis and treatment of viral disease. However, only a few such antibodies suitable for clinical use have been produced to date. We have previously shown that large panels of human recombinant monoclonal antibodies against a plethora of infectious agents, including herpes simplex virus types 1 and 2, can be established from phage display libraries. Here we demonstrate that facile cloning of recombinant Fab fragments against specific viral proteins in their native conformation can be accomplished by panning phage display libraries against viral glycoproteins "captured" from infected cell extracts by specific monoclonal antibodies immobilized on ELISA plates. We have tested this strategy by isolating six neutralizing recombinant antibodies specific for herpes simplex glycoprotein gD or gB, some of which are against conformationally sensitive epitopes. By using defined monoclonal antibodies for the antigen-capture step, this method can be used for the isolation of antibodies to specific regions and epitopes within the target viral protein. For instance, monoclonal antibodies to a nonneutralizing epitope can be used in the capture step to clone antibodies to neutralizing epitopes, or antibodies to a neutralizing epitope can be used to clone antibodies to a different neutralizing epitope. Furthermore, by using capturing antibodies to more immunodominant epitopes, one can direct the cloning to less immunogenic ones. This method should be of value in generating antibodies to be used both in the prophylaxis and treatment of viral infections and in the characterization of the mechanisms of antibody protective actions at the molecular level.
机译:人单克隆抗体在预防和治疗病毒性疾病方面具有相当大的潜力。然而,迄今为止,仅产生了少数几种适合临床使用的抗体。先前我们已经表明,可以从噬菌体展示库中建立针对大量感染因子(包括1型和2型单纯疱疹病毒)的大批人类重组单克隆抗体。在这里,我们证明,通过针对固定在ELISA板上的特异性单克隆抗体,针对从捕获的细胞提取物中“捕获”的病毒糖蛋白淘选噬菌体展示文库,可以轻松克隆针对其天然构象的针对特定病毒蛋白的重组Fab片段。我们已经通过分离六种对单纯疱疹糖蛋白gD或gB特异的中和重组抗体测试了该策略,其中一些抗体针对构象敏感表位。通过将定义的单克隆抗体用于抗原捕获步骤,该方法可用于分离针对目标病毒蛋白内特定区域和表位的抗体。例如,针对非中和性表位的单克隆抗体可以用于捕获步骤以克隆针对中和性表位的抗体,或者针对中和性表位的抗体可以用于克隆针对不同中和性表位的抗体。此外,通过使用捕获针对更多免疫优势表位的抗体,可以将克隆定向至免疫原性较低的表位。该方法在产生可用于预防和治疗病毒感染的抗体以及在分子水平上表征抗体保护作用机制的过程中应该具有价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号